272 related articles for article (PubMed ID: 18269664)
41. Efficacy of topical mesalazine compared with clobetasol propionate in treatment of symptomatic oral lichen planus.
Sardella A; Demarosi F; Oltolina A; Rimondini L; Carrassi A
Oral Dis; 1998 Dec; 4(4):255-9. PubMed ID: 10200704
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study.
Madan V; August PJ; Chalmers RJ
Clin Exp Dermatol; 2010 Jan; 35(1):27-30. PubMed ID: 19549244
[TBL] [Abstract][Full Text] [Related]
43. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
[TBL] [Abstract][Full Text] [Related]
44. Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report.
Sánchez AR; Sheridan PJ; Rogers RS
J Periodontol; 2004 Apr; 75(4):613-9. PubMed ID: 15152828
[TBL] [Abstract][Full Text] [Related]
45. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
[TBL] [Abstract][Full Text] [Related]
46. The effectiveness of 1% pimecrolimus cream in the treatment of oral erosive lichen planus.
Swift JC; Rees TD; Plemons JM; Hallmon WW; Wright JC
J Periodontol; 2005 Apr; 76(4):627-35. PubMed ID: 15857105
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of a novel mucoadhesive clobetasol patch for treatment of erosive oral lichen planus: A phase 2 randomized clinical trial.
Brennan MT; Madsen LS; Saunders DP; Napenas JJ; McCreary C; Ni Riordain R; Pedersen AML; Fedele S; Cook RJ; Abdelsayed R; Llopiz MT; Sankar V; Ryan K; Culton DA; Akhlef Y; Castillo F; Fernandez I; Jurge S; Kerr AR; McDuffie C; McGaw T; Mighell A; Sollecito TP; Schlieve T; Carrozzo M; Papas A; Bengtsson T; Al-Hashimi I; Burke L; Burkhart NW; Culshaw S; Desai B; Hansen J; Jensen P; Menné T; Patel PB; Thornhill M; Treister N; Ruzicka T
J Oral Pathol Med; 2022 Jan; 51(1):86-97. PubMed ID: 34907617
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of laser phototherapy in comparison to topical clobetasol for the treatment of oral lichen planus: a randomized controlled trial.
Dillenburg CS; Martins MA; Munerato MC; Marques MM; Carrard VC; Sant'Ana Filho M; Castilho RM; Martins MD
J Biomed Opt; 2014 Jun; 19(6):068002. PubMed ID: 24887747
[TBL] [Abstract][Full Text] [Related]
49. Comparison of topical clobetasol propionate 0.05% and topical tacrolimus 0.1% in the treatment of cutaneous lichen planus.
Özkur E; Aksu EK; Gürel MS; Savaş S
Postepy Dermatol Alergol; 2019 Dec; 36(6):722-726. PubMed ID: 31998001
[TBL] [Abstract][Full Text] [Related]
50. Topical tacrolimus in the management of peristomal pyoderma gangrenosum.
Lyon CC; Stapleton M; Smith AJ; Mendelsohn S; Beck MH; Griffiths CE
J Dermatolog Treat; 2001 Mar; 12(1):13-7. PubMed ID: 12171681
[TBL] [Abstract][Full Text] [Related]
51. Outcomes of oral lichen planus and oral lichenoid lesions treated with topical corticosteroid.
Gonzalez-Moles MA; Bravo M; Gonzalez-Ruiz L; Ramos P; Gil-Montoya JA
Oral Dis; 2018 May; 24(4):573-579. PubMed ID: 29121431
[TBL] [Abstract][Full Text] [Related]
52. Tacrolimus or clobetasol for treatment of oral lichen planus.
Shipley CA; Spivakovsky S
Evid Based Dent; 2016 Mar; 17(1):16. PubMed ID: 27012570
[TBL] [Abstract][Full Text] [Related]
53. [Neuropsychiatric disorders due to clobetasol propionate misuse].
Law Ping Man L; Poreaux C; Cuny JF; Javot L; Petitpain N; Barbaud A; Schmutz JL
Therapie; 2013; 68(3):179-81. PubMed ID: 23886466
[No Abstract] [Full Text] [Related]
54. Topical tacrolimus, triamcinolone acetonide, and placebo in oral lichen planus: a pilot randomized controlled trial.
Siponen M; Huuskonen L; Kallio-Pulkkinen S; Nieminen P; Salo T
Oral Dis; 2017 Jul; 23(5):660-668. PubMed ID: 28168769
[TBL] [Abstract][Full Text] [Related]
55. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
[TBL] [Abstract][Full Text] [Related]
56. An open trial of topical tacrolimus for erosive oral lichen planus.
Morrison L; Kratochvil FJ; Gorman A
J Am Acad Dermatol; 2002 Oct; 47(4):617-20. PubMed ID: 12271312
[TBL] [Abstract][Full Text] [Related]
57. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
[TBL] [Abstract][Full Text] [Related]
58. Management of a patient with severe erosive lichen planus in need of an immediate complete denture: a clinical report.
Rabanal A; Bral M; Goldstein G
J Prosthet Dent; 2007 May; 97(5):252-5. PubMed ID: 17547941
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of Topical Calcineurin Inhibitors in Oral Lichen Planus.
Sotoodian B; Lo J; Lin A
J Cutan Med Surg; 2015; 19(6):539-45. PubMed ID: 26088501
[TBL] [Abstract][Full Text] [Related]
60. [Pimecrolimus (Elidel) for therapy of lichen ruber mucosae].
Scheer M; Kawari-Mahmoodi N; Neugebauer J; Kübler AC
Mund Kiefer Gesichtschir; 2006 Nov; 10(6):403-7. PubMed ID: 17051364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
